According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$939.17. In 2021 the company made an earnings per share (EPS) of -HK$65.70 an increase over its 2020 EPS that were of -HK$86.80.